positive results by imipenem-EDTA disk synergy test. Conclusion MBL production was the main resistance mechanism in the 11 carbapenem resistant P. aeruginosa isolates collected, with multidrug resistance associating significantly with MBL production in P. aeruginosa from our institution.
Metallo-beta-lactamase (MBL) producing Pseudomonas aeruginosa has emerged as a threat to hospital infection control, due to its multi-drug resistance, especially in intensive care units (ICUs) .
Aims
This study was carried out to detect MBL producing P. aeruginosa isolates from medical and surgical ICUs, to compare and evaluate different phenotypic methods currently in use and to determine antibiograms. Method A prospective study was undertaken to detect MBLs in P. aeruginosa isolates obtained from various clinical samples. A total of 49 strains were recovered from patients admitted in inpatient wards and ICUs, and screened for imipenem resistance by Kirby Bauer disk diffusion method. Detection of MBLs was further done by imipenem-EDTA disk synergy test and combined disk test.
Results
Out of 49 isolates, 11 isolates (22.4 per cent) were imipenem resistant. All 11 imipenem resistant P. aeruginosa strains, when further tested, were positive for MBL production by combined disk test, but, only eight showed and combined disk test are simple cost-effective phenotypic tests for detection of MBL production in P. aeruginosa. 3. Routine screening of P. aeruginosa using inexpensive phenotypic tests like imipenem and imipenem + EDTA combined disk test should be an essential component of infection control in both ICU and non-ICU patients.
Background
Pseudomonas aeruginosa is a well-known isolate in hospital settings and has been frequently associated with nosocomial outbreaks among susceptible patients. 1 Owing to its persistence in the hospital environment, as a survival strategy an array of multidrug resistance mechanisms are often seen in such hospital isolates. 2 Consequently, treatment options are narrowed down to only few antibiotics. Carbapenems are the antibiotics of choice for severe pseudomonas infections. However, resistance to this novel antibiotic is increasing worldwide. 3 Carbapenem resistance in Pseudomonas aeruginosa is most commonly due to production of metallo-beta-lactamases (MBLs). 4 MBLs are broad-spectrum enzymes that hydrolyse 6 There is intense selection pressure, due to high usage of broad spectrum antibiotics in ICUs. This results in eradication of competitive flora and subsequent selection of multidrug-resistant strains. 6 In recent years, MBL genes have spread from P. aeruginosa to members of Enterobacteriaceae. 7 Notably, high morbidity and mortality rates (ranging between 27 per cent to 48 per cent) have been observed in critically ill patients. 8, 9 Furthermore, mortality rates are significantly higher in MBL producing P. aeruginosa (MBL-PA) compared to non-MBL-PA. 10 Currently, no standardised method for MBL detection has been proposed and despite polymerase chain reaction (PCR) being highly accurate and reliable, its accessibility is often limited to reference laboratories. 4 The aim of this study was to detect MBL producing P. aeruginosa isolates from medical and surgical ICUs, compare and evaluate different phenotypic methods currently in use, and determine antibiograms to guide clinicians in prescribing proper antibiotic and controlling hospital infection. Imipenem-EDTA combined disk method (CDT) was performed as described by Yong et al. 12 A lawn culture of test isolates was prepared. After allowing it to dry for five minutes, two imipenem discs, one with 0.5 M EDTA and the other a plain imipenem disc, were placed on the surface of agar plates approximately 30mm apart. The plates were incubated overnight at 37 O C. An increase in zone diameter of ≥ 7mm around imipenem+EDTA disk in comparison to imipenem disk alone indicated production of MBL ( Figure. 1).
Method

Figure 1: Combined disk test using imipenem and imipenem + EDTA. Imipenem + EDTA disk (on the right) produced ≥ 7mm larger zone of inhibition than the imipenem disk (on the left)
Imipenem-EDTA double disk synergy test (DDST) was performed as described by Lee et al. 13 Test organisms were inoculated on to plates with Mueller Hinton agar as recommended by CLSI. An imipenem (10μg) disk was placed 20mm centre to centre from a blank disk containing 10μL of 0.5 M EDTA (750μg). Enhancement of the zone of inhibition in the area between imipenem and EDTA disk in comparison with the zone of inhibition on the far side of the drug was interpreted as a positive result for MBL production ( Figure  2 ).
Figure 2: Imipenem-EDTA double disk synergy test (DDST). Imipenem disk (on the left) produced large synergistic zone of inhibition towards the imipenem + EDTA disk (on the right)
Antibiotic susceptibility of three randomly selected imipenem resistant isolates was done by VITEK 2 advanced expert system (bioMerieux Vitek Systems Inc, Hazelwood, France), by which minimum inhibitory concentrations (MICs) were determined for the following antibiotics: piperacillin, piperacillin/tazobactam, ticarcillin/clavulinic acid, ceftazidime, cefepime, cefoperazone, ceftriaxone, cefotaxime, amikacin, levofloxacin, ciprofloxacin and imipenem. International reference strain P. aeruginosa ATCC 27853 was used for quality control.
All findings were entered in an MS Excel data sheet and on completion of the study data was statistically analysed in SPSS software version 17.0. The data was expressed as mean ±SD and percentage. 
Results
Out of 320 samples examined during the study period, 49 P. aeruginosa strains were recovered from 42 (85.7 per cent) males and 7 (14.3 per cent) females admitted in inpatient wards and ICUs. These were screened for MBL production. Table 3 . P. aeruginosa with resistance to three or more antibiotic groups are considered multidrug resistant strains. Table 4 compares the prevalence of multidrug resistance among imipenem sensitive and imipenem resistant P. aeruginosa. All 49 patients were studied for risk factors and mortality. Although no mortality was reported in these patients during the study, longer hospital stay was particularly seen in patients with imipenem resistant P. aeruginosa infection ( Table 5 ). Among other risk factors in 11 patients harbouring imipenem resistant P. aeruginosa strains, four (36.3 per cent) patients were diabetic, one (9 per cent) was alcoholic and five (45.4 per cent) patients had a history of prior antibiotic use, especially ciprofloxacin, metronidazole and cefotaxime (Table 6 ). Discussion P. aeruginosa is a pervasive pathogen in hospital acquired infections, especially among critically ill patients. 6 Multidrug resistance in P. aeruginosa has appeared as an issue of great concern with emergence of MBL-PA. 6 Although simple phenotypic tests are available, these strains often escape detection during routine laboratory processing. 4 We compared different phenotypic detection methods currently in use and elucidated risk factors and prevalence of MBL-PA infections in our hospital and its impact in terms of mortality.
In this study, most cases of P. aeruginosa were from surgical inpatients, in contrast to medical wards. The most common specimens received were pus swab (55.1 per cent) and pus aspirates (12.2 per cent) followed by respiratory specimens. 15, 16 The preponderance of males can be explained by the greater number of cases from surgery and orthopaedic wards having more male patient admissions. Other authors also had similar findings. 15 2, 13 Since this study is only focused on P. aeruginosa isolates, ceftazidime resistance was not considered for the initial screening. 13 However, we found ceftazidime resistance in 9 out of 11 imipenem resistant P. aeruginosa isolates and the remaining two isolates had intermediate sensitivity.
In this group, all 11 strains were uniformly sensitive to polymyxin and colistin. Polymyxin and colistin are peptide antibiotics 17 and are the last resort of therapy in MBL-PA with additional resistance to aztreonam. 14 However, the high incidence of nephrotoxicity and neurotoxicity that is associated with these drugs limits their use. 18 Polymyxin resistance is uncommon among P.
aeruginosa and several studies have reported Multi Drug Resistant (MDR) strains being uniformly sensitive to polymyxin. 2, 19 Diverse resistance patterns have been described by different authors. 6, 16, 20, 21 6 These regional variations in susceptibility patterns reflect the antibiotic practices prevailing in regional hospitals. Our study shows lower resistance to most non-beta lactam agents compared to others which can be attributed to rational antibiotic usage.
In contrast to the common observation of high prevalence P. aeruginosa with multidrug resistance in ICU in different studies, 6 only four P. aeruginosa isolates were recovered from the ICU during the study period and all of them showed sensitivity to imipenem and most antipseudomonal drugs. Furthermore, no mortality was reported in these four ICU patients or the remaining 45 patients from other wards. High mortality and multidrug resistance among ICU patients with P. aeruginosa infection has been frequently reported by several authors. This may be related to excessive use of broad spectrum antibiotics, invasive procedures, associated septicaemia and higher comorbidities among ICU patients. 6, 8 However, in our case the study duration was very short and all P. aeruginosa isolates were sensitive to commonly used anti-pseudomonal drugs. Hence, these P. aeruginosa isolates were amenable to treatment. Moreover, good infection control measures and rational use of antibiotics in therapy in our hospital could explain zero mortality rates in these patients.
All 11 imipenem resistant P. aeruginosa isolates were tested for MBL production by DDST and CDT using imipenem and EDTA. Positive results were detected in all strains in CDT (100 per cent) and eight strains in DST (72 per cent). Although carbapenem resistant non-MBL-producing P. aeruginosa is not very rare, no such isolate was detected in this study. The prevalence of MBL production among P. aeruginosa in our hospital was 22.4 per cent, which is in accordance with other Indian studies. 6, 20 22 Despite conflicting observations of different authors, none of these phenotypic tests were optimal due to low sensitivity or specificity.
test and E test. 24 Some workers reported CDT to be satisfactory for screening despite its low specificity as it is an easy procedure and is simple to interpret. 12, 25 Others, however, found DST superior to and more reliable than CDT or modified Hodge test. 20 We found that CDT showed better correlation with the imipenem disk diffusion screening method. However, sensitivity and specificity of these tests could not be calculated since PCR was not done. CDT has less chance of subjective variation, since it measures the increase in inhibition zone above a cut off value. On the other hand, interpretation of DDST is more subjective. CDT and DDST both are limited by factors like temperature, aeration, pH and thickness of media. However, the synergy between imipenem and imipenem+EDTA disks are influenced by diffusion. EDTA must diffuse close to the imipenem disk and achieve a concentration with effective chelating activity to demonstrate a synergy. This may explain the difference in results of CDT and DDST found in our study. High-level resistance to beta-lactams and carbapenem resistant phenotype was identified by AES (Advanced Expert System) in two of these isolates.
Multidrug resistance is an emerging problem in P.
aeruginosa. 6, 14 MDR strains have been reported to cause outbreaks and greater mortality morbidity. 19, 26 Resistance to three or more antibiotic classes of anti-pseudomonal antibiotics viz. β-lactams, aminoglycosides and fluoroquinolones is considered as MDR in P. aeruginosa. 3 We detected 17 MDR strains of which 10 (58.8%) were MBL producing isolates. Although in our study MDR and MBL production has shown significant association (p value = 9 This is in accordance with our observation. We found 45.4 per cent patients had prior exposure to antibiotic use, especially ciprofloxacin, metronidazole and cefotaxime.
The main limitation of this study was the short duration of the study period and small sample size. The small number of cases may not be representative of hospital patient population under study. Because of the short duration of the study our observations might have been affected by seasonal trends of patient admission in different wards of hospital. Hence, positive associations found in our study may not be conclusive and need further evaluation. Imipenem MIC was not detected for all isolates. Molecular gold standard tests for detection of MBL genes were not done. Consequently, sensitivity and specificity of phenotypic methods could not be computed.
Conclusion
MBL production was the main resistance mechanism in carbapenem resistant P. aeruginosa and multidrug resistance was frequently detected among MBL producing P. aeruginosa in our institution. Prevalence of MBL producing P. aeruginosa was similar to other Indian hospitals, but these MBL producing strains were more sensitive to non-beta lactam drugs. Imipenem resistance detected by disk diffusion test was a reliable screening test that correlated well with the combined disk test method. 0.00004), it may be inconclusive due to the small sample size.
Several risk factors have been described in MBL-PA infection in literature. 6, 14 Duration of hospital stay of more than eight days was found to be significantly associated with MBL-PA infections in various studies. 6, 9, 14, 19 We found 8 out of 11 cases of MBL-PA infection had hospitalisation of more than eight days. However, for this study length of stay was found not to be significant (p value = 0.177360 and odd ratio =
